BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Clinical trial NCT01296932 · COMPLETED
Trial details
- NCT number
- NCT01296932
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-11
- Primary completion
- 2017-05-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.